Drug:
Reaction: INJECTION SITE PAIN
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25122252 |
US |
49 | 1 |
Injection site pain, |
||||
TRALOKINUMAB-LDRM, |
||||
| 302 | 25122340 |
US |
54 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 303 | 25122349 |
US |
49 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 304 | 25122533 |
US |
36 | 1 |
Injection site erythema, Injection site pain, Deep tissue injury, |
||||
RISPERIDONE, |
||||
| 305 | 25122674 |
CA |
||
Disease susceptibility, Asthenia, Colitis ulcerative, Bronchitis, Pneumonia, Sinusitis, Nasopharyngitis, Injection site pain, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DEXLANSOPRAZOLE, HYDROCHLOROTHIAZIDE, MESALAMINE, RAMIPRIL, ROSUVASTATIN, ACETAMINOPHEN, |
||||
| 306 | 25122790 |
US |
62 | 2 |
Blood glucose increased, Injection site pain, Injection site coldness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 307 | 25122821 |
CA |
||
Diabetes mellitus, Fungal infection, Cough, Asthma, Rash, Injection site pain, Incorrect dose administered, |
||||
CICLESONIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MONTELUKAST, ALBUTEROL SULFATE, |
||||
| 308 | 25122879 |
US |
39 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 309 | 25122885 |
US |
65 | 2 |
Extra dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 310 | 25123182 |
US |
64 | 1 |
Injection site pain, Product administered at inappropriate site, Wrong technique in device usage process, |
||||
DUPILUMAB, GABAPENTIN, HYDROXYZINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALLOPURINOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ROSUVASTATIN CALCIUM, |
||||
| 311 | 25123197 |
US |
40 | 2 |
Injection site pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 312 | 25123226 |
US |
1 | |
Injection site pain, Product preparation error, |
||||
DUPILUMAB, |
||||
| 313 | 25123246 |
US |
2 | |
Injection site haemorrhage, Injection site swelling, Injection site pain, |
||||
DUPILUMAB, |
||||
| 314 | 25123264 |
US |
15 | 1 |
Injection site pain, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 315 | 25123283 |
US |
69 | 1 |
Pain in extremity, Swelling, Pyrexia, Urticaria, Pruritus, Conjunctivitis, Injection site pain, Rash, |
||||
DUPILUMAB, DUPILUMAB, IPRATROPIUM BROMIDE, HYOSCYAMINE SULFATE, IPRATROPIUM BROMIDE AND ALBUTEROL, TESTOSTERONE, TESTOSTERONE,, PREDNISONE, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, MELOXICAM, METHOCARBAMOL, METHOCARBAMOL TABLETS, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ROFLUMILAST, SIMVASTATIN, MOMETASONE FUROATE, MOMETASONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, |
||||
| 316 | 25123315 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 317 | 25123318 |
US |
11 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 318 | 25123321 |
US |
13 | 1 |
Injection site haemorrhage, Injection site pain, |
||||
DUPILUMAB, |
||||
| 319 | 25123349 |
US |
31 | 2 |
Injection site urticaria, Injection site swelling, Injection site pain, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 320 | 25123355 |
US |
83 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 321 | 25123906 |
CA |
63 | 1 |
Intercepted product preparation error, Inappropriate schedule of product administration, Device leakage, Injection site pain, Hot flush, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 322 | 25124021 |
US |
49 | 1 |
Injection site pain, Rash, Syringe issue, |
||||
DUPILUMAB, |
||||
| 323 | 25124049 |
US |
46 | 2 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 324 | 25124063 |
US |
71 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 325 | 25124086 |
US |
50 | 2 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 326 | 25124232 |
US |
29 | 2 |
Extra dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 327 | 25124268 |
CA |
88 | 1 |
Incorrect dose administered, Injection site pain, |
||||
LEUPROLIDE ACETATE, |
||||
| 328 | 25124273 |
CA |
91 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 329 | 25124275 |
CA |
59 | 1 |
Injection site pain, Hot flush, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 330 | 25124524 |
US |
53 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 331 | 25124621 |
US |
19 | 2 |
Anxiety, Injection site pain, |
||||
DUPILUMAB, |
||||
| 332 | 25124770 |
DE |
64 | 2 |
Injection site dryness, Nausea, Dyspepsia, Abdominal pain, Injection site pain, Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, AMLODIPINE, RAMIPRIL, BISOPROLOL FUMARATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 333 | 25124960 |
US |
34 | 2 |
Abscess, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 334 | 25124964 |
31 | 2 | |
Injection site mass, Injection site pain, |
||||
CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 335 | 25125212 |
US |
1 | |
Injection site pain, Injection site swelling, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 336 | 25125446 |
US |
65 | 2 |
Injection site pain, Accidental underdose, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 337 | 25125449 |
US |
35 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 338 | 25125596 |
US |
70 | 2 |
Injection site pain, Product dose omission issue, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 339 | 25125712 |
US |
16 | 2 |
Eczema, Rash, Injection site pain, Product dose omission in error, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 340 | 25125744 |
US |
52 | 2 |
Accidental overdose, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 341 | 25125844 |
US |
67 | |
Product dose omission issue, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 342 | 25126141 |
US |
1 | |
Fear of injection, Injection site pain, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 343 | 25115735 |
US |
44 | 2 |
Vision blurred, Injection site swelling, Injection site erythema, Injection site pain, Oral herpes, |
||||
DUPILUMAB, |
||||
| 344 | 25115768 |
US |
54 | 2 |
Injection site pain, Device physical property issue, |
||||
PEGFILGRASTIM, |
||||
| 345 | 25115792 |
US |
58 | 1 |
Injection site pain, |
||||
DULAGLUTIDE, |
||||
| 346 | 25115801 |
US |
33 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 347 | 25115803 |
US |
34 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 348 | 25115809 |
US |
24 | 2 |
Migraine, Product dose omission issue, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 349 | 25115863 |
US |
20 | 2 |
Injection site pain, Condition aggravated, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 350 | 25115933 |
US |
57 | 2 |
Injury associated with device, Wrong patient received product, Product administered at inappropriate site, Injection site pain, Injection site warmth, Injection site induration, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 351 | 25115937 |
US |
59 | 1 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 352 | 25115954 |
US |
30 | 2 |
Migraine, Injection site pain, Injection site swelling, Injection site pruritus, |
||||
DUPILUMAB, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, |
||||
| 353 | 25116067 |
US |
2 | |
Injection site pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 354 | 25116104 |
US |
58 | 1 |
Migraine, Incorrect dose administered by device, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 355 | 25116113 |
US |
37 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 356 | 25116146 |
CA |
79 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 357 | 25116156 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 358 | 25116160 |
US |
63 | 2 |
Rash pruritic, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 359 | 25116172 |
US |
48 | 1 |
Injection site pain, Lack of injection site rotation, |
||||
DUPILUMAB, |
||||
| 360 | 25116219 |
US |
18 | 1 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 361 | 25116254 |
US |
48 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 362 | 25116396 |
US |
62 | 1 |
Nephrolithiasis, Catheter site papule, Catheter site erythema, Injection site pain, Catheter site pain, Catheter site mass, Catheter site warmth, Injection site mass, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ROSUVASTATIN, |
||||
| 363 | 25116429 |
US |
52 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 364 | 25116436 |
US |
35 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 365 | 25116611 |
US |
2 | |
Injection site pain, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, LISINOPRIL, |
||||
| 366 | 25116767 |
US |
62 | 2 |
Wrong technique in product usage process, Product administered at inappropriate site, Incorrect dose administered, Injection site pain, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 367 | 25116768 |
US |
23 | 2 |
Injection site pain, Incorrect dose administered, |
||||
DULAGLUTIDE, |
||||
| 368 | 25116774 |
US |
44 | 2 |
Sinus disorder, Product with quality issue administered, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 369 | 25116945 |
US |
76 | 1 |
Device leakage, Product dose omission issue, Injection site pain, |
||||
GUSELKUMAB, |
||||
| 370 | 25117045 |
US |
25 | 2 |
Injection site pain, Injection site mass, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 371 | 25117051 |
US |
63 | 1 |
Injection site pain, |
||||
INSULIN GLARGINE, |
||||
| 372 | 25117368 |
US |
36 | 1 |
Injection site mass, Injection site pain, |
||||
CABOTEGRAVIR, PROMETHAZINE HYDROCHLORIDE, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, |
||||
| 373 | 25117476 |
US |
61 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 374 | 25117516 |
GB |
38 | 1 |
Neuropathy peripheral, Chromaturia, Visual impairment, Abdominal pain, Muscle spasms, Urine odour abnormal, Blood urine present, Injection site erythema, Nausea, Injection site pain, Fatigue, Vomiting, Chills, Injection site inflammation, Tremor, Urine abnormality, Drug ineffective, Incorrect dose administered by device, Device mechanical issue, |
||||
GLATIRAMER ACETATE, GLATIRAMER, |
||||
| 375 | 25117975 |
US |
58 | 1 |
Weight decreased, Injection site pain, Injection site mass, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, SEMAGLUTIDE, |
||||
| 376 | 25117982 |
US |
55 | 2 |
Injection site pain, Injection site haemorrhage, Injection site injury, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 377 | 25118287 |
US |
65 | 2 |
Device difficult to use, Drug dose omission by device, Injection site pain, |
||||
EVOLOCUMAB, |
||||
| 378 | 25118336 |
US |
14 | 1 |
Injection site pain, Device physical property issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 379 | 25118341 |
US |
12 | |
Injection site pain, Injection site mass, Injection site rash, Injection site pruritus, |
||||
SOMATROGON-GHLA, ARIPIPRAZOLE, ATOMOXETINE, |
||||
| 380 | 25118379 |
FR |
||
Injection site pain, |
||||
SOMATROGON-GHLA, |
||||
| 381 | 25118491 |
US |
64 | 1 |
Injection site pain, Product colour issue, Product deposit, Poor quality product administered, |
||||
TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE, |
||||
| 382 | 25118614 |
CA |
76 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, |
||||
| 383 | 25118620 |
CA |
75 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, |
||||
| 384 | 25118623 |
CA |
72 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, |
||||
| 385 | 25118626 |
CA |
64 | 1 |
Dyspnoea, Injection site pain, Fatigue, Hot flush, Dizziness, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 386 | 25118632 |
US |
34 | 1 |
Injection site pain, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 387 | 25118748 |
US |
1 | |
Weight increased, Injection site haemorrhage, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 388 | 25118769 |
FR |
10 | 2 |
Injection site pain, |
||||
SOMATROGON-GHLA, |
||||
| 389 | 25118787 |
CA |
77 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 390 | 25118788 |
CA |
75 | 1 |
Injection site pain, Hot flush, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 391 | 25118790 |
CA |
64 | 1 |
Injection site pain, |
||||
LEUPROLIDE ACETATE, |
||||
| 392 | 25118883 |
US |
73 | 2 |
Throat clearing, Wound, Contusion, Myalgia, Erythema, Oral herpes, Injection site pain, |
||||
DUPILUMAB, |
||||
| 393 | 25118908 |
US |
59 | 2 |
Injection site pain, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 394 | 25118953 |
US |
42 | 2 |
Injection site pain, Injection site pruritus, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 395 | 25118973 |
US |
31 | 1 |
Balance disorder, Eczema, Pruritus, Injection site pain, |
||||
DUPILUMAB, |
||||
| 396 | 25119003 |
US |
||
Injection site pain, |
||||
DUPILUMAB, |
||||
| 397 | 25119039 |
US |
2 | |
Product dose omission issue, Injection site pain, |
||||
LANADELUMAB-FLYO, LANADELUMAB-FLYO, LANADELUMAB-FLYO, |
||||
| 398 | 25119042 |
US |
72 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 399 | 25119116 |
US |
63 | 2 |
Injection site mass, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 400 | 25119140 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, POTASSIUM CHLORIDE, MAGNESIUM OXIDE, SERTRALINE HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LEVOTHYROXINE SODIUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28